14th edition

Format
HYBRID

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG

December 8th ,2025

ONLINE MEETINGS

Stand F10

2022 Edition

Paras Biopharmaceuticals Finland Oy

Finland

Company activities & offerings are categorized in 3 major areas:
1. Contract development & microbial biologics manufacturing (CDMO).
2. Development of Recombinant expression systems and process technologies for biologics and biosimilars.
3. Paras Biopharmaceuticals has developed and is offering Recombinant Bioprocess enzymes.

Scroll to Top
  • No products in the cart.